2022. Incidence of adverse events in patients with metastatic breast cancer during use of standard and on/off capecitabine protocols. Research, Society and Development. 11, 8 (Jun. 2022), e3711830426. DOI:https://doi.org/10.33448/rsd-v11i8.30426.